BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2016 - Global Markets Direct - Market Research

BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2016

BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2016 - Global Markets Direct - Market Research
BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2016
Published Jun 22, 2016
60 pages — Published Jun 22, 2016
Price US$ 1,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2016, provides an overview of the BioMarin Pharmaceutical Inc.s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by BioMarin Pharmaceutical Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of BioMarin Pharmaceutical Inc.
- The report provides overview of BioMarin Pharmaceutical Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses BioMarin Pharmaceutical Inc.s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features BioMarin Pharmaceutical Inc.s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate BioMarin Pharmaceutical Inc.s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for BioMarin Pharmaceutical Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding BioMarin Pharmaceutical Inc.s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and sco

  
Source:
Document ID
GMDHC08070CDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables51
  List of Figures51
BioMarin Pharmaceutical Inc. Snapshot61
  BioMarin Pharmaceutical Inc. Overview61
  Key Information61
  Key Facts61
BioMarin Pharmaceutical Inc. Research and Development Overview73
  Key Therapeutic Areas73
BioMarin Pharmaceutical Inc. Pipeline Review104
  Pipeline Products by Stage of Development101
  Pipeline Products Monotherapy111
  Pipeline Products Out-Licensed Products121
    Out-Licensed Products/Combination Treatment Modalities131
BioMarin Pharmaceutical Inc. Pipeline Products Glance145
  BioMarin Pharmaceutical Inc. Late Stage Pipeline Products141
    Filing rejected/Withdrawn Products/Combination Treatment Modalities141
    Phase III Products/Combination Treatment Modalities151
  BioMarin Pharmaceutical Inc. Clinical Stage Pipeline Products161
    Phase II Products/Combination Treatment Modalities161
    Phase I Products/Combination Treatment Modalities171
  BioMarin Pharmaceutical Inc. Early Stage Pipeline Products181
    Preclinical Products/Combination Treatment Modalities181
BioMarin Pharmaceutical Inc. Drug Profiles1918
  amifampridine phosphate191
    Product Description191
    Mechanism of Action191
    R&D Progress192
  pegvaliase211
    Product Description211
    Mechanism of Action211
    R&D Progress212
  reveglucosidase alfa231
    Product Description231
    Mechanism of Action231
    R&D Progress231
  cerliponase alfa241
    Product Description241
    Mechanism of Action241
    R&D Progress241
  vosoritide251
    Product Description251
    Mechanism of Action251
    R&D Progress251
  BMN-250261
    Product Description261
    Mechanism of Action261
    R&D Progress261
  BMN-270271
    Product Description271
    Mechanism of Action271
    R&D Progress271
  Antisense RNAi Oligonucleotides to Activate Dysferlin for Dysferlinopathies281
    Product Description281
    Mechanism of Action281
    R&D Progress281
  PRO-052291
    Product Description291
    Mechanism of Action291
    R&D Progress292
  PRO-055311
    Product Description311
    Mechanism of Action311
    R&D Progress312
  PRO-135331
    Product Description331
    Mechanism of Action331
    R&D Progress331
  PRO-289341
    Product Description341
    Mechanism of Action341
    R&D Progress341
  RG-3250351
    Product Description351
    Mechanism of Action351
    R&D Progress351
  Small Molecule for Sanfilippo Syndrome361
    Product Description361
    Mechanism of Action361
    R&D Progress361
BioMarin Pharmaceutical Inc. Pipeline Analysis374
  BioMarin Pharmaceutical Inc. Pipeline Products by Target371
  BioMarin Pharmaceutical Inc. Pipeline Products by Route of Administration381
  BioMarin Pharmaceutical Inc. Pipeline Products by Molecule Type391
  BioMarin Pharmaceutical Inc. Pipeline Products by Mechanism of Action401
BioMarin Pharmaceutical Inc. Recent Pipeline Updates4113
BioMarin Pharmaceutical Inc. - Dormant Projects541
BioMarin Pharmaceutical Inc. - Discontinued Pipeline Products551
  Discontinued Pipeline Product Profiles551
    BMN-044551
    BMN-045551
    BMN-053551
    drisapersen551
BioMarin Pharmaceutical Inc. Locations And Subsidiaries562
  Head Office561
  Other Locations &Subsidiaries562
BioMarin Pharmaceutical Inc. - Key Manufacturing Facilities581
Appendix592
  Methodology591
  Coverage591
  Secondary Research591
  Primary Research591
  Expert Panel Validation591
  Contact Us591
  Disclaimer601

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2016" Jun 22, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/BioMarin-Pharmaceutical-Inc-Product-Pipeline-Review-2016-2088-15986>
  
APA:
Global Markets Direct - Market Research. (2016). BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2016 Jun 22, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/BioMarin-Pharmaceutical-Inc-Product-Pipeline-Review-2016-2088-15986>
  
US$ 1,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.